Rajiv Shukla

Rajiv Shukla is the Chairman & CEO of Carmell Corporation, a bio-aesthetics company focusing on the application of alllogeneic human platelet secretome for topical physician dispensed cosmetics. Rajiv also holds the title of Director on the Board of Directors at Humacyte, a regenerative medicine biotech company, as well as being a Partner at SPAC Research, a data and insights provider for the SPAC industry. Additionally, Rajiv has held various leadership roles in companies such as Constellation Alpha Capital Corp., InflammX Therapeutics Inc, and Pipavav Defence and Offshore Engineering Company Limited, showcasing their extensive experience in the healthcare and biotech industries.